Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?

Brain and Language

Volumn 117, Issue 1, 2011, Pages 23-27

  Güngör, Levent ^a   Terzi, Murat ^a   Onar, Musa Kazim ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Aphasia; Cerebrovascular diseases; Ischemic stroke; Piracetam; Recovery

Indexed keywords

PIRACETAM; PLACEBO;

ADULT; AGITATION; ANXIETY; APHASIA; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL IRRITATION; HUMAN; IRRITABILITY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VOMITING;

APHASIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PIRACETAM; SINGLE-BLIND METHOD; STROKE; TREATMENT OUTCOME;

EID: 79953746846     PISSN: 0093934X     EISSN: 10902155     Source Type: Journal    
DOI: 10.1016/j.bandl.2010.11.003     Document Type: Article

References (45)

1. Bakheit A.M.O. Drug treatment of poststroke aphasia. Expert Review of Neurotherapeutics 2004, 4(2):211-217.
2. Berthier M.L. Poststroke aphasia. Epidemiology, pathophysiology and treatment. Drugs and Aging 2005, 22(2):163-182.
3. Berthier M.L., Green C., Lara P., Higueras C., Barbancho B., Davila G., et al. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Annals of Neurology 2009, 65:577-585.
4. Bhogal S.K., Teasell R., Speechley M. Intensity of aphasia therapy, impact on recovery. Stroke 2003, 34:987-993.
5. Boissezon X., Peran P., Boysson C., Demonet J.F. Pharmacotherapy of aphasia: Myth or reality?. Brain and Language 2007, 102:114-125.
6. Brown P., Steiger M.J., Thompson P.D., Rothwell J.C., Day B.L., Salama M., et al. Effectiveness of piracetam in cortical myoclonus. Movement Disorders 1993, 8:63-68.
7. Buckner R.L., Corbetta M., Schatz J., Raichle M.E., Petersen S.E. Preserved speech abilities and compensation following prefrontal damage. Proceedings of the National Academy of Science 1996, 93:1249-1253.
8. Cohen L., Chaaban B., Habert M.O. Transient improvement of aphasia with zolpidem. New England Journal of Medicine 2004, 350:949-950.
9. Croisile B., Trillet M., Fondarai J., Laurent B., Mauguiere F., Billardon M. Long-term and high dose piracetam treatment of Azheimer's disease. Neurology 1993, 43:301-305.
10. De Deyn P.P., de Reuck J., Debert W., Vlietinck R., Orgogozo J.M. Treatment of acute ischemic stroke with piracetam. Stroke 1997, 28:2347-2352.
11. De Reuck J., Van Vleymen B. The clinical safety of high-dose piracetam - Its use in the treatment of acute stroke. Pharmacopsychiatry 1999, 32(Suppl.):33-37.
12. Enderby P., Broeckx J., Hospers W., Schildermans F., Debert W. Effect of piracetam on recovery and rehabilitation after stroke: A double-blind, placebo-controlled study. Clinical Neuropharmacology 1994, 17(4):320-331.
13. Fioravanti M., Bergamasco B., Bocola V., Martucci N., Nappi G., Neri G., et al. A multicentre, double-blind, controlled study of piracetam vs placebo in geriatric patients with nonvascular mild-moderate impairment in cognition. New Trends in Clinical Neuropharmacology 1991, 5(1):26-35.
14. Floel A., Cohen L.G. Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiology of Disease 2010, 37:243-251.
15. Greener J., Enderby P., Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database of Systematic Reviews 2000, 2:CD000425.
16. Greener J., Enderby P., Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database of Systematic Reviews 2001, 1:CD000424.
17. Huber W. The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry 1999, 32(Suppl.):38-43.
18. Huber W., Willmes K., Poeck K., van Vleymen B., Debert W. Piracetam as an adjuvant to language therapy for aphasia: A randomized double-blind placebo controlled pilot study. Archieves of Physical Medicine and Rehabilitation 1997, 78:245-250.
19. Jordan L.C., Hillis A.E. Disorders of speech and language: Aphasia, apraxia and dysarthria. Current Opinion in Neurology 2006, 19:580-585.
20. Kelly H., Brady M.C., Enderby P. Speech and language therapy for aphasia following stroke. Cochrane Database of Systematic Reviews 2010, 5:CD000425.
21. Kessler J., Thiel A., Karbe H., Heiss W.D. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 2000, 31:2112-2116.
22. Liepert J. Pharmacotherapy in restorative neurology. Current Opinion in Neurology 2008, 21:639-643.
23. Mavis İ., Colay K., Topbas S., Tanri{dotless}dag O. Standardization, validity and reliability study of Gülhane Aphasia Test-2 (GAT-2). Turkish Journal of Neurology 2007, 13(2):89-98.
24. Mimura M., Kato Mo., Kato Ma., et al. Prospective and retrospective studies of recovery in aphasia. Brain 1998, 121:2083-2094.
25. Müller W.E., Koch S., Scheuer K., Rostock A., Bartsch R. Effects of piracetam on membrane fluidity in the aged mouse, rat and human brain. Biochemical Pharmacology 1997, 53:135-140.
26. Nietsch P., Wörz K. Cerebrovascular insufficiency in old age. Therapie Woche 1989, 39:2909-2915.
27. Ohyama M., Senda M., Kitamura S., et al. Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasics. A PET activation study. Stroke 1996, 27(5):897-903.
28. Orgogozo J.M. Piracetam in the treatment of acute stroke. Pharmacopsychiatry 1999, 32(Suppl. 1):25-32.
29. Ozbudak S.D., Alti{dotless}nok N., Aydi{dotless}n G., Koseoglu F. Functional and cognitive progress in aphasic patients with traumatic brain injury during post-acute phase. Brain Injury 2006, 20:1383-1390.
30. Platt D., Horn J., Summa J.D., Schmitt-Ruth R., Kauntz J., Kronert E. On the efficacy of piracetam in geriatric patients with acute cerebral ischemia: A clinically controlled double-blind study. Archives of Gerontology and Geriatrics 1993, 16:149-164.
31. Pulvermüller F., Berthier M.L. Aphasia therapy on a neuroscience basis. Aphasiology 2008, 22(6):563-599.
32. Ricci S., Celani M.G., Cantisani T.A., Righetti E. Piracetam in acute stroke: A systematic review. Journal of Neurology 2000, 247:263-266.
33. Rosenhall U., Deberdt W., Friberg U., Kerr A., Oosterveld W. Piracetam in patients with chronic vertigo: Results of a double blind placebo controlled study. Clinical Drug Investigation 1996, 11:251-260.
34. Saur D., Lange R., Baumgaertner A., Schraknepper V., Willmes K., Rijntjes M., et al. Dynamics of language reorganization after stroke. Brain 2006, 129:1371-1384.
35. Small S.L., Llano D.A. Biological approaches to aphasia treatment. Current Neurology and Neuroscience Reports 2009, 9(6):443-445.
36. Szelies B., Mielke R., Kesller J., Hiss W.D. Restitution of alpha-topography by piracetam in post-stroke aphasia. International Journal of Clinical Pharmacology and Therapeutics 2001, 39(4):152-157.
37. Tanri{dotless}dag O. Aphasia 1995, Nobel Medical Publishing, Istanbul, Turkey.
38. Vernon M.W., Sorkin E.M. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs and Aging 1991, 1(1):17-35.
39. Vleymen B.V., Zandijcke M.V. Piracetam in the treatment of myoclonus: An overview. Acta Neurologica Belgica 1996, 96:270-280.
40. Walker-Batson D., Curtis S., Natarajan R., Ford J., Dronkers N., Salmeron E., et al. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 2001, 32:2093-2098.
41. Weiller C. Imaging recovery from stroke. Experimental Brain Research 1998, 123:13-17.
42. Wheble P.C.R., Sena E.S., Macleod M.R. A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovascular Disease 2008, 25:5-11.
43. WHO Special report from the World Health Organization. Report of the WHO Task Force on stroke and other cerebrovascular disorder. Stroke 1989, 20:1407-1431.
44. Winnicka K., Tomasiak M., Bielawska A. Piracetam an old drug with novel properties. Acta Poloniae Pharmaceutica 2005, 62(5):405-409.
45. Yavuzer G., Güzelküçük S., Küçükkdeveci A., Gök H., Ergin S. Aphasia rehabilitation in patients with stroke. International Journal of Rehabilitation Research 2001, 24:241-244.